Clinical trial
Epigenetic Regulation of Activity and Severity of Fibrous Dysplasia in Bone: mirDYS Study.
NCT03838991 is registered in ClinicalTrials.gov with Hospices Civils de Lyon as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Epigenetic Regulation of Activity and Severity of Fibrous Dysplasia in Bone: mirDYS Study.
- Lead sponsor
- Hospices Civils de Lyon
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 10, 2019
- Completion date
- March 24, 2023
- Enrollment
- 24 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.